© 2021 MJH Life Sciences and Contemporary Clinic. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary Clinic. All rights reserved.
February 03, 2018
The FDA has updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.